A Share Of The Blame

As a scientist, past editor, member of editorial boards, and occasional published poet, I found the article on scientific writing timely and to the point, although not surprising (K.S. Brown, The Scientist, Jan. 20, 1997, page 16). The chastening of scientists as members of C.P. Snow's "other culture" is a popular pastime, but editors and publishers bear a share of the blame for substandard scientific writing. I have commented here (E.D. Kilbourne, Proceedings of the American Philosophical Soc

Written byEdwin Kilbourne
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

As a scientist, past editor, member of editorial boards, and occasional published poet, I found the article on scientific writing timely and to the point, although not surprising (K.S. Brown, The Scientist, Jan. 20, 1997, page 16). The chastening of scientists as members of C.P. Snow's "other culture" is a popular pastime, but editors and publishers bear a share of the blame for substandard scientific writing.

I have commented here (E.D. Kilbourne, Proceedings of the American Philosophical Society, 140[3]:338-49, 1996) on embarrassing attempts at levity in the editorial columns in Nature and Science. Copy editing, formerly overzealous and officious, now appears to be virtually absent. (See articles in English by authors whose first language is not English.) Even The Scientist appears to have its problems. (See headline on first page of the issue of Jan. 20, 1997, referring to an "unnecessary redundancy.")

Regarding that old favorite for discussion, the overuse ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies